For more information or confidential assistance
Call 800-306-3180

Pradaxa Bleeding Problems and Adverse Event Reports

Pradaxa FDA warning
For the second year in a row, the controversial anticoagulant Pradaxa leads all other drugs in adverse event reports submitted to the Federal Drug Administration (FDA).  According to an analysis by the Institute for Safe Medication Practices (ISMP), in 2012 the FDA Adverse Event Reporting System... Read More

Rispderal Induced Gynecomastia Sparks Litigation

Risperdal Lawsuit
Risperdal received FDA approval in 1993. It is an atypical antipsychotic medication used to treat schizophrenia and symptoms of bipolar disorder, in addition to symptoms of irritability in autistic children. Some doctors have also prescribed it to treat obsessive-compulsive disorder, stuttering, Tourettes syndrome, and severe... Read More

New Study Examines Pradaxa Internal Bleeding Risks

diane 35 blood clot risk
Manufactured by Boehringer Ingelheim, Pradaxa is promoted as a more convenient alternative to its predecessor warfarin for stroke prevention, as the medication entails less rigorous medical monitoring. Despite this convenience, the anticoagulant, which has no known antidote to quell bleeding events, has been linked to... Read More